Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
$57.69
+0.1%
$57.06
$52.97
$59.77
$2.33B0.63228,000 shs209,995 shs
LianBio stock logo
LIAN
LianBio
$0.20
+2.6%
$0.20
$0.27
$4.99
$21.61M0.231.04 million shs20,912 shs
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
$42.09
-0.7%
$42.10
$40.73
$43.68
$63.14M0.284,930 shs12,352 shs
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
$24.55
+0.7%
$24.08
$21.10
$26.49
$352.19M0.9486,463 shs116,320 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
-0.07%+2.22%+0.09%-1.87%+7.14%
LianBio stock logo
LIAN
LianBio
0.00%-4.95%+0.11%-4.95%-41.47%
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
+0.02%+1.51%+0.07%+1.39%+3.94%
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
-0.29%+2.78%-3.48%-1.59%+3.47%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
LianBio stock logo
LIAN
LianBio
N/AN/AN/AN/AN/AN/AN/AN/A
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
1.4538 of 5 stars
1.13.01.70.02.10.81.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
0.00
N/AN/AN/A
LianBio stock logo
LIAN
LianBio
0.00
N/AN/AN/A
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
0.00
N/AN/AN/A
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
2.25
Hold$25.082.17% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/AN/AN/AN/AN/A
LianBio stock logo
LIAN
LianBio
N/AN/AN/AN/A$2.71 per shareN/A
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
N/AN/AN/AN/AN/AN/A
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
$46.93M7.50$4.00 per share6.13$27.12 per share0.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/A19.26N/AN/AN/AN/AN/A
LianBio stock logo
LIAN
LianBio
-$110.29M-$0.81N/AN/AN/AN/A-33.17%-30.19%N/A
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
$8.93M$2.489.908.24N/A22.01%15.53%4.80%5/7/2025 (Estimated)

Latest PAB, LIAN, AOR, and SAR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q4 2025
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
$0.77N/AN/AN/A$32.86 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
$1.552.69%N/AN/AN/A
LianBio stock logo
LIAN
LianBio
N/AN/AN/AN/AN/A
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
$1.754.16%N/AN/AN/A
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
$3.0012.22%N/A120.97%N/A

Latest PAB, LIAN, AOR, and SAR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2025
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
monthly$0.2511.6%6/5/20256/5/20256/24/2025
2/19/2025
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
monthly$0.2511.6%6/5/20256/5/20256/24/2025
5/1/2025
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
$0.2512.31%5/6/20255/7/20255/22/2025
2/18/2025
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
quarterly$0.7411.62%4/8/20254/8/20254/24/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/AN/AN/A
LianBio stock logo
LIAN
LianBio
N/A
10.06
10.06
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
N/AN/AN/A
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
0.14
0.33
0.33
CompanyEmployeesShares OutstandingFree FloatOptionable
iShares Core 60/40 Balanced Allocation ETF stock logo
AOR
iShares Core 60/40 Balanced Allocation ETF
N/A40.35 millionN/ANot Optionable
LianBio stock logo
LIAN
LianBio
110108.06 million99.86 millionNot Optionable
PGIM Active Aggregate Bond ETF stock logo
PAB
PGIM Active Aggregate Bond ETF
N/A1.50 millionN/ANot Optionable
Saratoga Investment Corp. stock logo
SAR
Saratoga Investment
3,21114.35 million12.62 millionOptionable

Recent News About These Companies

Huge Saratoga County apartment development sold
Upstate Capital names new President/CEO

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
iShares Core 60/40 Balanced Allocation ETF stock logo

iShares Core 60/40 Balanced Allocation ETF NYSEARCA:AOR

$57.69 +0.07 (+0.12%)
Closing price 04:10 PM Eastern
Extended Trading
$57.81 +0.12 (+0.21%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iShares Growth Allocation ETF, formerly iShares S&P Growth Allocation Fund (the Fund), is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Risk Growth Index (the Growth Allocation Index). The Growth Allocation Index seeks to measure the performance of an asset allocation strategy targeted to a growth-focused risk profile. The Fund is designed for investors seeking moderate capital appreciation and opportunity for current income and capital preservation. The Fund's investment advisor is BlackRock Fund Advisors.

LianBio stock logo

LianBio NASDAQ:LIAN

$0.20 +0.01 (+2.56%)
As of 04/30/2025

LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis and meibomian gland disease; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor and NX-13 for ulcerative colitis and Crohn's disease; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03 for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.

PGIM Active Aggregate Bond ETF stock logo

PGIM Active Aggregate Bond ETF NYSEARCA:PAB

$42.09 -0.30 (-0.71%)
As of 04:10 PM Eastern

The PGIM Active Aggregate Bond ETF (PAB) is an exchange-traded fund that is based on the Bloomberg US Aggregate Bond index. The fund is an actively managed fixed income fund that holds USD-denominated securities issued by both government and corporate entities. These securities must be investment grade and have maturities of more than one year. PAB was launched on Apr 15, 2021 and is managed by PGIM.

Saratoga Investment stock logo

Saratoga Investment NYSE:SAR

$24.55 +0.18 (+0.74%)
Closing price 03:59 PM Eastern
Extended Trading
$24.55 0.00 (0.00%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Saratoga Investment Corp. is a business development company specializing in leveraged and management buyouts, acquisition financings, growth financings, recapitalization, debt refinancing, and transitional financing transactions at the lower end of middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, co-investments, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. The firm prefers to invest in aerospace, automotive aftermarket and services, business products and services, consumer products and services, education, environmental services, industrial services, financial services, food and beverage, healthcare products and services, logistics, distribution, manufacturing, restaurants services, food services, software services, technology services, specialty chemical, media and telecommunications. It seeks to invest in the United States. The firm primarily invests $5 million to $50 million in companies having EBITDA of $2 million or greater and revenues of $8 million to $250 million. The firm prefer to take a majority stake. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. was formed on 2007 and is based in New York, New York with an additional office in Florham Park, New Jersey.